Soroka Medical Center
Beersheba, 84101, Israel
NCT Number: NCT00826137
Prospective randomized double-blind study on the effect of prebiotics (inulin and fructo-oligosaccharides) in the prevention of antibiotic-associated diarrhea in children.
Looking for future studies?
Notify Me6 month–14 year
All sexes
Interventional
Phase 3
Beersheba, 84101, Israel
Group will get either the product or placebo blindly throughout antibiotic treatment with additional 14 days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Supplement during antibiotic treatment+14 days.
Other names: Placebo is base powder of product with no oligosaccharides.
Placebo is base powder of product with no oligosaccharides.
Time frame: During antibiotic treatment+14 days
Time frame: During antibiotic treatment+14 days
Soroka University Medical Center
Other
Prebiotics in the Prevention of Antibiotic-associated Diarrhea in Children
Acronym: WGAAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07234448
Antibiotic-associated Diarrhea
Urbino, Italy
View Trial DetailsNCT05845073
Antibiotic-associated Diarrhea
Berlin, Weißenseer Weg, Germany
View Trial DetailsNCT04414722
Antibiotic-associated Diarrhea
Washington D.C., District of Columbia, United States
View Trial DetailsNCT03181516
Antibiotic-associated Diarrhea
Washington D.C., District of Columbia, United States
View Trial Details